| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0213-005X(08)76510-8 |
| P698 | PubMed publication ID | 18680694 |
| P2093 | author name string | Mireia Arnedo Valero | |
| P2860 | cites work | Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations | Q44796890 |
| Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir | Q45145810 | ||
| Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection | Q45750903 | ||
| HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing | Q46492432 | ||
| Clinical and immunogenetic correlates of abacavir hypersensitivity | Q46500012 | ||
| HLA-B*5701 clinical testing: early experience in the United States | Q46988876 | ||
| The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost | Q64128722 | ||
| Involvement of T cells in drug-induced allergies | Q77324777 | ||
| Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses | Q77723690 | ||
| Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis | Q77769027 | ||
| Abacavir rechallenge has to be avoided in case of hypersensitivity reaction | Q78131191 | ||
| A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome | Q83143933 | ||
| Genetic variations in HLA-B region and hypersensitivity reactions to abacavir | Q28214097 | ||
| Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci | Q28249307 | ||
| Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir | Q33956146 | ||
| Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons | Q33998597 | ||
| Type 1/Type 2 immunity in infectious diseases | Q34105379 | ||
| Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir | Q34117815 | ||
| Th(1)/Th(2) responses to drugs | Q34133692 | ||
| Cytokine measurement techniques for assessing hypersensitivity | Q34133707 | ||
| An overview of the immune system | Q34280088 | ||
| Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity | Q34332730 | ||
| Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study | Q34535561 | ||
| HLA-B*5701 screening for hypersensitivity to abacavir | Q34747145 | ||
| The danger hypothesis--potential role in idiosyncratic drug reactions | Q35035447 | ||
| Molecular aspects of drug recognition by specific T cells | Q35045799 | ||
| T helper type-2 cytokine responses: potential therapeutic targets. | Q35193671 | ||
| Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. | Q35372676 | ||
| Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity | Q35873680 | ||
| Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines | Q36070849 | ||
| Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant | Q37356747 | ||
| Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population | Q39789621 | ||
| Uncertainties of routine HLA B*5701 testing in black African HIV cohorts in the UK. | Q42010168 | ||
| Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir | Q43527201 | ||
| Hypersensitivity related to abacavir in two members of a family | Q43776204 | ||
| Abacavir hypersensitivity reaction | Q43933908 | ||
| Risk factor analysis of hypersensitivity reactions to abacavir | Q43997777 | ||
| Haptenation of sulfonamide reactive metabolites to cellular proteins | Q44187706 | ||
| Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones | Q44329279 | ||
| Reasons for Early Abacavir Discontinuation in HIV-Infected Patients | Q44602385 | ||
| Epidemiological risk factors for hypersensitivity reactions to abacavir* | Q44606314 | ||
| P407 | language of work or name | Spanish | Q1321 |
| P304 | page(s) | 34-39 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Infectious Diseases and Clinical Microbiology | Q15766978 |
| P1476 | title | HLA-B*5701 and hypersensitivity reactions to abacavir. Study methods and clinical relevance | |
| P478 | volume | 26 Suppl 6 |
Search more.